The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
about
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lungRole of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataThe use and misuse of positron emission tomography in lung cancer evaluationStaging of cutaneous melanoma.Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis.Appropriateness of imaging for lung cancer staging in a national cohort(18)F-fluorodeoxyglucose positron emission tomography/computed tomography accuracy in the staging of non-small cell lung cancer: review and cost-effectivenessPET-specific parameters and radiotracers in theoretical tumour modelling.SBRT in operable early stage lung cancer patients.Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.Functional imaging in lung cancerClinical and surgical-pathological staging in early non-small cell lung cancer.Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.Staging non-small cell lung cancerFDG-PET parameters predicting mediastinal malignancy in lung cancerPositron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsPositron emission tomography: clinical applications in oncology. Part 1.Is 18F FDG PET-CT cost effective in lung cancer?A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204)18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.Identification of false-negative and false-positive diagnoses of lymph node metastases in non-small cell lung cancer patients staged by integrated (18F-)fluorodeoxyglucose-positron emission tomography/computed tomography: A retrospective cohort stud(18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients.The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.PET/CT for staging and monitoring non small cell lung cancerPositron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).PET and PET-CT in radiation treatment planning for lung cancer.Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer.Novel molecular imaging in lung and pleural diseases.Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules.Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.Molecular Acoustic Angiography: A New Technique for High-resolution Superharmonic Ultrasound Molecular ImagingAssessment of Molecular Acoustic Angiography for Combined Microvascular and Molecular Imaging in Preclinical Tumor Models.The influence of respiratory motion on the cumulative SUV-volume histogram and fractal analyses of intratumoral heterogeneity in PET/CT imaging.Hybrid imaging is the future of molecular imaging.Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis.A study on usefulness evaluation of SUV measured in mini-PACS for each one of PET/CT equipment.Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis.Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
P2860
Q24187743-4B1974D4-8737-40DF-9F7D-04E8654FE77FQ24550866-394410F9-2C68-4512-895B-72209C90AF0FQ24633254-0F1A8A1B-2823-45A6-A1BE-94A7EAE0E2F0Q27021838-BD9FD75F-75A1-4919-9509-2F938898624FQ33484062-576514DA-FBB0-47B4-A08A-779567706FA7Q33913747-5AD63CEF-01A1-4CD7-8521-3BF8614C45B6Q34332850-5A5EAEB7-6A82-4D44-A769-31ED6FAF8653Q34546800-18E6E296-AF6A-4A11-A391-56DF5551F86CQ35151586-D89AA056-2B94-4F07-8C80-A8573E45872BQ35200592-5A991F25-F99B-4FC8-A4F6-609B89400191Q35266969-D9E7E86F-F6B8-485B-A202-312E5AA26AD2Q35550676-554362BD-64A3-404D-B5A4-353903F60D41Q35569308-3C4BC6D8-92D3-4024-96D2-6F5FB30EF43AQ35941636-A8C409F7-CBDA-495E-9031-B9417BCECA24Q36129173-EE5B016E-A336-4561-B121-C21FE1788DD1Q36216501-E17F3B23-E41D-46CF-810E-D997472629DAQ36325435-F7C82702-AFEE-426D-B11D-DBE1D9348091Q36334917-28FF12AA-5113-494C-99FE-257609610543Q36788474-A0175064-00ED-4DA0-ABB1-A35B51BB656CQ36882714-B34D17DF-AC57-4EC6-86D1-481F07C02AC7Q37016566-0FD720BC-153C-44C7-8DBB-E0C17FEDB002Q37060407-4BB72A24-36E4-4447-A9B3-F23B5790F520Q37062963-648A46EF-E2E2-4B5A-9A6E-5F2892012C47Q37131297-2291FA93-9F86-4616-9DB7-0169FF7E9431Q37292826-DF476B32-A2A1-49B8-ACC0-9EDC95080D6CQ37301288-17A45368-DE6D-4927-8684-ADDE505C6CF9Q37732292-23D2D36C-BC5A-4329-B8F8-BA8118A1AA1CQ37829768-3D5A0A80-6126-4082-A707-A3AFCBDA7ED1Q37927164-919D4909-1340-4FDA-8801-824629BDFCAFQ38316795-7B7B5D78-284F-4874-A15D-36B4696E1ED4Q38692070-F9138B5B-FAC5-4370-BE30-62C14BEEDD56Q38705115-8333B408-2AAC-4DA2-983D-FF70A8DA7D90Q38810997-E4C292EF-642B-44EC-9755-E512A28F04ADQ38831825-3AE092BF-FE14-4D7F-83B0-65448ED21EC7Q39938308-5F2134B5-D996-485D-A896-A7F158C00A32Q40199132-2113822A-39C6-479C-9B96-E9B7AB724658Q41474160-45868243-D153-4236-B2C4-BB1C73B48C9FQ41957628-3D594F2F-1D65-409D-9298-D15B6ADA36C4Q43667576-2DFC5EB6-3A00-424D-AC98-EAED1C1D69F5Q44639914-20364E0A-801B-436C-89F7-38B66A312CBE
P2860
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@en
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@nl
type
label
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@en
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@nl
prefLabel
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@en
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@nl
P2093
P1476
The accuracy of integrated PET ...... ith nonsmall cell lung cancer.
@en
P2093
Alfred A Bartolucci
Ayesha S Bryant
Buddhiwardhani Ojha
James M Mountz
Vanguru Raghuveer
P304
1017-23; discussion 1017-23
P356
10.1016/J.ATHORACSUR.2004.02.067
P407
P577
2004-09-01T00:00:00Z